|
2019 Conference Publication Preliminary safety and efficacy of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus-targeted T-cell immunotherapy for patients with progressive forms of multiple sclerosisPender, M., Hodgkinson, S., Broadley, S., Lindsey, J., Ioannides, Z., Munson, D., Rasor, K., Forozan, F., Foubert, P., Aftab, B., Gamelin, L., Ye, W. and Willmer, J. (2019). Preliminary safety and efficacy of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus-targeted T-cell immunotherapy for patients with progressive forms of multiple sclerosis. 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11-13 September 2019 . London, United Kingdom: Sage Publications. |
|
2019 Conference Publication Preliminary phase 1 safety of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus (EBV)-targeted T-cell immunotherapy for patients with progressive multiple sclerosis (MS)Pender, M. P., Hodgkinson, S., Broadley, S., Lindsey, J. W., Ioannides, Z. A., Aftab, B. T., Munson, D., Rasor, K., Forozan, F., Foubert, P., Gamelin, L., Feng, A. and Willmer, J. (2019). Preliminary phase 1 safety of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus (EBV)-targeted T-cell immunotherapy for patients with progressive multiple sclerosis (MS). 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 29-July 2, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2018 Conference Publication Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivoBagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. AAN 70th Annual Meeting, Los Angeles, CA United States, 21-27 April 2018. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.90.15_supplement.s52.001 |
|
2018 Conference Publication Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivoBagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. 70th Annual Meeting of the American Academy of Neurology (AAN), Los Angeles, California, 21-27 April 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Conference Publication Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialPender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Conference Publication Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosisPender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications. |
|
2016 Conference Publication Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosisGreer, J. M., Muller, D. M., Beasley, S. J., Trifilieff, E. and Pender, M. P. (2016). Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley. |
|
2015 Conference Publication Impaired T cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael, Csurhes, Peter and Burrows, Scott (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, EC1Y 1SP United Kingdom: SAGE PUBLICATIONS LTD. doi: 10.1177/1352458515616527 |
|
2014 Conference Publication Characterization of genetic variants in the NFKBIA promoter region in multiple sclerosisYan, Jun, Greer, Judith, Mccombe, Pamela, Pender, Michael and Consortium, Anzgene (2014). Characterization of genetic variants in the NFKBIA promoter region in multiple sclerosis. 12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, Nov 09-13, 2014. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.jneuroim.2014.08.141 |
|
2014 Conference Publication PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and analysis of in vitro effects of PLP1 mutationsCloake, Nancy, Yan, Jun, Pender, Michael, Aminian, Atefeh and Greer, Judith (2014). PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and analysis of in vitro effects of PLP1 mutations. 12th International Congress of Neuroimmunology (ISNI), Mainz Germany, 9-13 November 2014. Amsterdam, The Netherlands: Elsevier. doi: 10.1016/j.jneuroim.2014.08.268 |
|
2013 Conference Publication Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapyPender, M. P., Csurhes, P. A., Smith, C., Beagley, L., Hooper, K. D., Raj, M., Coulthard, A., Burrows, S. R. and Khanna, R. (2013). Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapy. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen Denmark, 2 - 5 October 2013. London, United Kingdom: Sage Publications Ltd.. doi: 10.1177/1352458513502429 |
|
2012 Conference Publication Investigation of gene mutations in the NFKBIA promoter region in patients with multiple sclerosisYan, J., Pender, M.P., Liu, J., McCombe, P.A., Greer, J.M. and ANZgene Consortium (2012). Investigation of gene mutations in the NFKBIA promoter region in patients with multiple sclerosis. Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications. |
|
2012 Conference Publication Building the hypothesis: CD8 T cell deficiency impairs immune control of Epstein-Barr virus infection in multiple sclerosis and worsens with agePender, M.P. (2012). Building the hypothesis: CD8 T cell deficiency impairs immune control of Epstein-Barr virus infection in multiple sclerosis and worsens with age. Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications. |
|
2012 Conference Publication Consistent patterns of clinical and laboratory findings in patients with co-existent autoimmune thyroid disease and autoimmune demyelinating disease in the central nervous systemGreer, Judith and Pender, Michael (2012). Consistent patterns of clinical and laboratory findings in patients with co-existent autoimmune thyroid disease and autoimmune demyelinating disease in the central nervous system. 11th International Congress of Neuroimmunology (ISNI), Boston MA., United States, 4-8 November 2012. Amsterdam, The Netherlands: Elsevier. |
|
2012 Conference Publication Development of specific therapeutic agents for multiple sclerosis (MS)Greer, J.M., Moxey, N.C., Pender, M.P. and Trifilieff, E. (2012). Development of specific therapeutic agents for multiple sclerosis (MS). Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications. |
|
2011 Conference Publication CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosisPender, M. P., Csurhes, P. A., Pfluger, C. M. M. and Burrows, S. R. (2011). CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2010 Conference Publication Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelinationPonsonby, AL, Lucas, RM, van der Mei, I, Dear, K, Taylor, BV, McMichael, AJ, Valery, P, Dwyer, T, Chapman, C, Pender, MP, Coulthard, A, Williams, D and Kilpatrick, TJ (2010). Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination. 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, San Antonio TX, JUN, 2010. |
|
2010 Conference Publication Elevated levels of autoantibodies against neurotransmitter receptor-related molecules in schizophreniaJones, Amanda, Mowry, Bryan, Pender, Michael and Greer, Judith (2010). Elevated levels of autoantibodies against neurotransmitter receptor-related molecules in schizophrenia. 10th Congress of the International-Society-of-Neuroimmunology (ISNI), Sitges SPAIN, OCT 26-30, 2010. |
|
2010 Conference Publication Epstein Barr viral infection and onset of central nervous system demyelinationLucas, Robyn M., Ponsonby, Ane-Louise, Burrows, J., Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terence, Kilpatrick, Trevor J., McMichael, Anthony J., Taylor, Bruce V., Valery, Patricia, van der Mei, Ingrid, Williams, D and Pender, Michael P. (2010). Epstein Barr viral infection and onset of central nervous system demyelination. 15th Annual ACTRIMS Meeting Americas Committee for Treatment and Research in Multiple Sclerosis, San Antonio, TX, United States, 5 June 2010. London, United Kingdom: Sage Publications. doi: 10.1177/13524585100160081301 |
|
2009 Conference Publication Lower vitamin D status at first clinical diagnosis of central nervous system demyelination compared to matched controlsLucas, Robyn M., Ponsonby, Anne-Louise, Dear, Keith, McMichael, Anthony J., Pender, Michael P., Taylor, Bruce V., Chapman, Caron, Coulthard, Alan, Dwyer, Terence, Kilpatrick, Trevor J., Valery, Patricia, van der Mei, David Ingrid and Williams, David (2009). Lower vitamin D status at first clinical diagnosis of central nervous system demyelination compared to matched controls. 14th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis/Consortium for Multiple Sclerosis Centers, Atlanta GA, 27-30 May 2009. United Kingdom: Sage Publications. doi: 10.1177/1352458509348507 |
